Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02755805
Other study ID # PRO09010473
Secondary ID K12HD055931
Status Completed
Phase N/A
First received April 25, 2016
Last updated October 5, 2017
Start date July 2009
Est. completion date December 2012

Study information

Verified date October 2017
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cognitive impairments occur frequently after stroke, and are associated with significant long-term activities of daily living (ADL) disability and poor quality of life. This research study will undertake an innovative approach addressing cognitive impairments, by examining a new patient-centered functionally-relevant rehabilitation intervention that teaches individuals with cognitive impairments to manage their deficits to reduce ADL disability.


Description:

Cognitive impairments are characterized by problems sustaining attention in distracting conditions, shifting attention between different task demands, and using working memory to consistently execute intended actions, and as a result limit the ability to execute routine ADLs. Presently there are no interventions that have demonstrated robust effectiveness in reducing disability among individuals with cognitive impairments after stroke. Recent findings suggest that individuals with cognitive impairments may experience ADL disability in part because they have difficulty engaging in, and benefiting from rehabilitation programs as they are currently delivered. In other words, individuals with cognitive impairment, due to the nature of their impairments, have difficulty learning and applying adaptive strategies as they are currently provided during traditional rehabilitation training. Therefore, interventions that train individuals with cognitive impairments a new way to learn and apply adaptive strategies may help them benefit from rehabilitation programs and reduce long-term disability. Cognitive Orientation to daily Occupation Performance (CO-OP) is a strategy training approach that trains individuals to identify problems in the performance of daily activities, develop strategies to address these problems, and monitor their own performance in the course of their daily routines. Therefore, CO-OP teaches individuals to "take charge" of their rehabilitation, and develop adaptive behaviors to "work around" cognitive impairments to meet their goals. The proposed project examines whether CO-OP facilitates reductions in ADL disability and improvements in rehabilitation engagement among individuals with cognitive impairments after acute stroke.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- primary diagnosis of acute stroke

- admission to acute inpatient rehabilitation

- impairment in cognitive functions (Quick Executive Interview = 3)

Exclusion Criteria:

- dementia diagnosis (as indicated in the medical record)

- severe aphasia as indicated by score = 2 on the Boston Diagnostic Aphasia Examination (3rd Edition) Severity Rating Scale (BDAE-3)

- current major depressive disorder (unless treated and in partial remission), bipolar or any other psychotic disorder (Primary Care Evaluation of Mental Disorders)

- drug or alcohol abuse within 3 months (Mini-International Neuropsychiatric Interview)

- anticipated length of stay less than 5 days

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CO-OP

Attention Control


Locations

Country Name City State
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in Independence With Activities of Daily Living (Functional Independence Measure) Between Groups Over Time Difference between groups in mean scores (computed from Functional Independence Measure total scores) over time were examined with mixed effects models.
The Functional Independence Measure contains 18 items with a total score ranging from 18-126 is obtained (18=complete dependence/total assistance with basic self-care and mobility activities; 126=complete independence with basic self-care and mobility activities). Total scores were calculated at baseline, rehabilitation discharge, month 3, and month 6 for each participant, and mean total scores were calculated fro each group at each time point.
Baseline, rehabilitation discharge, month 3, month 6
Secondary Difference in Executive Function- Inhibition, CWI (Color Word Interference Inhibition Scale) Difference mean scaled scores (Color Word Interference Inhibition Scale) between groups over time using mixed effects models.
The Color Word Interference Inhibition Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function. Scaled scores were generated at baseline, month 3, and month 6 for each participant, and mean scaled scores were computed for each group at each time point.
Baseline, 3 months, 6 months
Secondary Difference in Executive Function - Cognitive Flexibility, CWI (Color Word Interference Switching Scale) Difference between groups in mean scaled scores (Color Word Interference Switching Scale) over time using mixed effects models.
The Cognitive Flexibility Scale raw scores were converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function. Scaled scores were generated at baseline, month 3, and month 6 for each participant, and mean scaled scores were computed for each group at each time point.
Baseline, 3 months, 6 months
Secondary Differences in Apathy Symptoms Between Groups Over Time Difference in mean Apathy Evaluation Scale total scores were examined between groups over time using repeated measures fixed effects models.
The Apathy Evaluation Scale measures lack of motivation or interest in goal-directed activities. The scale has 18 items yielding a total score of 18 (indicating absence of apathy) to 72 (indicating severe apathy). Total scores were generated for each participant at each time, and mean scores were computed for each group at each time point.
Baseline, 3 months, 6 months
See also
  Status Clinical Trial Phase
Completed NCT01934621 - Adapting Daily Activity Performance Through Strategy Training N/A
Completed NCT03872999 - Attentional Control N/A